loxicodegol (NKTR-181) - Nektar Therapeutics
Nektar Therapeutics: J.P.Morgan Healthcare Conference (Nektar Therapeutics) - Jan 17, 2016 - "NKTR-181: Phase 2 Human Abuse Liability Trial"; "NKTR-181 has significantly lower "drug high" ratings than oxycodone (p < 0.0001)" 
P2 data • Pain
http://www.nektar.com/pdf/2016_JPM-NKTR-FINAL.pdf
 
Jan 17, 2016
 
.
 
9488ce1f-de97-46ac-9fbb-a89e85315bae.jpg